Crossmark

Short-course radiotherapy combined with CAPOX and Toripalimab for the total neoadjuvant therapy of locally advanced rectal cancer: a randomized, prospective, multicentre, double-arm, phase II trial (TORCH)

Crossref DOI link: https://doi.org/10.1186/s12885-022-09348-z

Published Online: 2022-03-15

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Yaqi

Shen, Lijun

Wan, Juefeng

Zhang, Hui

Wu, Ruiyan

Wang, Jingwen

Wang, Yan

Xu, Ye

Cai, Sanjun

Zhang, Zhen

Xia, Fan http://orcid.org/0000-0001-8185-8663
Funding

Funding for this research was provided by:

Wu Jie Ping Medical Foundation (HYHX2021010)
License Information

Text and Data Mining valid from 2022-03-15

Version of Record valid from 2022-03-15
More Information

Article History

Received: 17 December 2021

Accepted: 28 February 2022

First Online: 15 March 2022

Declarations

:

: This study was conducted in compliance with Declaration of Helsinki principles. All procedures involving human subjects were approved by the Ethics Committee of Fudan University Shanghai Cancer Center. All patients signed informed consent forms before recruitment.

: Not Applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below